ATP13A2 and Lewy body dementia: It remains unclear, however, whether accumulated α-synuclein causes reductions in ATP13A2 protein levels or if a decrease in functional ATP13A2 protein levels renders neurons vulnerable to α-synuclein toxicity in Lewy body diseases.